a developer of pharmaceutical products for the treatment of cancers
Industry Biotechnology
A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.
Ticker / NAME | Correlation To ONCY | 1D Price Change % | ||
---|---|---|---|---|
ONCY | 100% | -1.94% | ||
SRRK - ONCY | 38% Loosely correlated | +0.44% | ||
RIGL - ONCY | 33% Poorly correlated | +0.18% | ||
ABCL - ONCY | 32% Poorly correlated | -5.48% | ||
RCUS - ONCY | 28% Poorly correlated | -4.02% | ||
DNA - ONCY | 27% Poorly correlated | -15.00% | ||
More |
Ticker / NAME | Correlation To ONCY | 1D Price Change % |
---|---|---|
ONCY | 100% | -1.94% |
cancer theme (82 stocks) | 18% Poorly correlated | -2.35% |
pharmaceuticals theme (159 stocks) | 18% Poorly correlated | -1.90% |
drugs theme (254 stocks) | 17% Poorly correlated | -1.67% |
treatment theme (56 stocks) | 14% Poorly correlated | -1.02% |
north america theme (186 stocks) | 11% Poorly correlated | -0.01% |
More |